Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

April’s top stories: Roche’s prostate cancer test, Medtronic’s divestiture of monitoring business

Roche launched a new diagnostic test called anti-p504s (SP116) Rabbit Monoclonal Primary Antibody for prostate cancer, and Cardinal Health signed a definitive $6.1bn agreement to acquire Medtronic's MIT Group’s patient care, deep vein thrombosis, and nutritional insufficiency businesses. Medicaldevice-network.com wraps-up the key headlines from April 2017.

Go Top